Related references
Note: Only part of the references are listed.Superhydrophobic material may enable adjustable drug release
Alice O'Hare
THERAPEUTIC DELIVERY (2012)
Vaginal Film Drug Delivery of the Pyrimidinedione IQP-0528 for the Prevention of HIV Infection
Anthony S. Ham et al.
PHARMACEUTICAL RESEARCH (2012)
Superhydrophobic Materials for Tunable Drug Release: Using Displacement of Air To Control Delivery Rates
Stefan T. Yohe et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
Electrospun cellular microenvironments: Understanding controlled release and scaffold structure
Andreas Szentivanyi et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Hormonal Contraception and HIV-1 Transmission
Catherine A. Blish et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2011)
Non-aqueous silicone elastomer gels as a vaginal microbicide delivery system for the HIV-1 entry inhibitor maraviroc
Claire J. Forbes et al.
JOURNAL OF CONTROLLED RELEASE (2011)
The Nonnucleoside Reverse Transcriptase Inhibitor MIV-150 in Carrageenan Gel Prevents Rectal Transmission of Simian/Human Immunodeficiency Virus Infection in Macaques
R. Singer et al.
JOURNAL OF VIROLOGY (2011)
Technological advances in electrospinning of nanofibers
Wee-Eong Teo et al.
SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS (2011)
The role of acidification in the inhibition of Neisseria gonorrhoeae by vaginal lactobacilli during anaerobic growth
Michelle A. Graver et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2011)
Development and characterization of a vaginal film containing dapivirine, a non-nucleoside reverse transcriptase inhibitor (NNRTI), for prevention of HIV-1 sexual transmission
Ayman Akil et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2011)
Dissolution Improvement of Electrospun Nanofiber-Based Solid Dispersions for Acetaminophen
Deng-Guang Yu et al.
AAPS PHARMSCITECH (2010)
Glycerol Monolaurate Inhibits Candida and Gardnerella vaginalis In Vitro and In Vivo but Not Lactobacillus
Kristi L. Strandberg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Combining prevention of HIV-1, other sexually transmitted infections and unintended pregnancies: Development of dual-protection technologies
David R. Friend et al.
ANTIVIRAL RESEARCH (2010)
Advances in microbicide vaginal rings
R. Karl Malcolm et al.
ANTIVIRAL RESEARCH (2010)
Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets
Sanjay Garg et al.
ANTIVIRAL RESEARCH (2010)
Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse
Thomas R. Moench et al.
BMC INFECTIOUS DISEASES (2010)
Third generation solid dispersions of ferulic acid in electrospun composite nanofibers
Deng-Guang Yu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
In Vitro and Ex Vivo Testing of Tenofovir Shows It Is Effective As an HIV-1 Microbicide
Lisa C. Rohan et al.
PLOS ONE (2010)
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
Quarraisha Abdool Karim et al.
SCIENCE (2010)
Reverse Transcriptase Inhibitors as Potential Colorectal Microbicides
Carolina Herrera et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Simultaneous Determination of Maraviroc and Raltegravir in Human Plasma by HPLC-UV
Stefania Notari et al.
IUBMB LIFE (2009)
Glycerol monolaurate prevents mucosal SIV transmission
Qingsheng Li et al.
NATURE (2009)
Glycerol Monolaurate and Dodecylglycerol Effects on Staphylococcus aureus and Toxic Shock Syndrome Toxin-1 In Vitro and In Vivo
Ying-Chi Lin et al.
PLOS ONE (2009)
Targeted Delivery of PSC-RANTES for HIV-1 Prevention using Biodegradable Nanoparticles
Anthony S. Ham et al.
PHARMACEUTICAL RESEARCH (2009)
Glycerol Monolaurate Does Not Alter Rhesus Macaque (Macaca mulatta) Vaginal Lactobacilli and Is Safe for Chronic Use
Patrick M. Schlievert et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
A Phase I study of the functional performance, safety and acceptability of the BufferGel® Duet™
Susan A. Ballagh et al.
CONTRACEPTION (2008)
SILCS diaphragm: postcoital testing of a new single-size contraceptive device
Jill L. Schwartz et al.
CONTRACEPTION (2008)
Identification of Gammaretroviruses Constitutively Released from Cell Lines Used for Human Immunodeficiency Virus Research
Yasuhiro Takeuchi et al.
JOURNAL OF VIROLOGY (2008)
The influence of hormonal contraceptive use on HIV-1 transmission and disease progression
Jared M. Baeten et al.
CLINICAL INFECTIOUS DISEASES (2007)
Development of vaginal rings for sustained release of nonhormonal contraceptives and anti-HIV agents
Young A. Han et al.
CONTRACEPTION (2007)
Preclinical testing of candidate topical microbicides for anti-human immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture
James E. Cummins et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Use of cyclodextrins to manipulate plasma membrane cholesterol content: Evidence, misconceptions and control strategies
Raphael Zidovetzki et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2007)
Sexual and Reproductive Health 1 -: Sexual and reproductive health:: a matter of life and death
Anna Glasier et al.
LANCET (2006)
Squeezing flows of vaginal gel formulations relevant to microbicide drug delivery
Sarah L. Kieweg et al.
JOURNAL OF BIOMECHANICAL ENGINEERING-TRANSACTIONS OF THE ASME (2006)
Investigation of drug release and matrix degradation of electrospun poly(DL-lactide) fibers with paracetanol inoculation
Wenguo Cui et al.
BIOMACROMOLECULES (2006)
Glycerol monolaurate inhibits the effects of gram-positive select agents on eukaryotic cells
ML Peterson et al.
BIOCHEMISTRY (2006)
Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings
RK Malcolm et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity
P Dorr et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection
SR Abner et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future research directions
AM Minnis et al.
SEXUALLY TRANSMITTED INFECTIONS (2005)
Evaluation of buccal methyl-β-cyclodextrin toxicity on human oral epithelial cell culture model
L Boulmedarat et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Glycerol monolaurate inhibits virulence factor production in Bacillus anthracis
SM Vetter et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Efficacy of nonhormonal vaginal contraceptives from a hydrogel delivery system
BB Saxena et al.
CONTRACEPTION (2004)
In vitro release of nonoxynol-9 from silicone matrix intravaginal rings
K Malcolm et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers:: a randomised controlled trial
L Van Damme et al.
LANCET (2002)
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy
XP Wei et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis
A Wald et al.
JOURNAL OF INFECTIOUS DISEASES (2002)
The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission
RN Fichorova et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120
CA Derdeyn et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
